Details for 2018752172
Up to date per 01.04.2026
Actions
Details for 2018752172
Granted/Registered
European Patent
24.06.2020 A
29.09.2021 B1
16.08.2017
EP
17382570
C07D 401/04 20060101AFI20190222BHEP
Owner
GlaxoSmithKline Intellectual Property Development LimitedGSK Medicines Research Centre, Gunnels Wood Road Stevenage, SG1 2NYGB
Bioversys AGTechnologiepark Basel Hochbergerstrasse 60c4057 BaselCH
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
PORRAS DE FRANCISCO, EstherGlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ochoa Tres Cantos 28760 MadridES
REMUIÑAN-BLANCO, Modesto JesúsGlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ochoa Tres Cantos 28760 MadridES
BOUROTTE, Marilyne74 avenue du kemmel 59840 PerenchiesFR
DEPREZ, Benoit19 rue des Célestines 59000 LilleFR
WILLAND, Nicolas8 rue de la Halle 59000 LilleFR
Information about Fees